IsoTag™ LV Reagent
Lentiviral vector purification
Key Facts
About Isolere Bio
Isolere Bio is a private, early-revenue stage company providing a platform technology for purifying biologics. Its IsoTag™ reagents use a novel mechanism combining affinity binding and liquid-liquid phase separation to capture, concentrate, and purify targets like AAV and lentiviral vectors directly in solution, bypassing traditional chromatography. Acquired by filtration leader Donaldson in 2023, Isolere now operates as part of Donaldson's Life Sciences division, aiming to address critical bottlenecks in bioprocessing for gene therapy manufacturing. The company offers evaluation kits and is actively collaborating with partners to integrate its scalable purification solutions.
View full company profileAbout Isolere Bio
Isolere Bio is a private, early-revenue stage company providing a platform technology for purifying biologics. Its IsoTag™ reagents use a novel mechanism combining affinity binding and liquid-liquid phase separation to capture, concentrate, and purify targets like AAV and lentiviral vectors directly in solution, bypassing traditional chromatography. Acquired by filtration leader Donaldson in 2023, Isolere now operates as part of Donaldson's Life Sciences division, aiming to address critical bottlenecks in bioprocessing for gene therapy manufacturing. The company offers evaluation kits and is actively collaborating with partners to integrate its scalable purification solutions.
View full company profile